Today: 20 May 2026
Lam Research Stock (LRCX) After Hours Today (Dec. 17, 2025): Why Shares Dropped, the Late Bounce, and What to Watch Before Tomorrow’s Open
18 December 2025
5 mins read

Lam Research Stock (LRCX) After Hours Today (Dec. 17, 2025): Why Shares Dropped, the Late Bounce, and What to Watch Before Tomorrow’s Open

Lam Research Corporation (NASDAQ: LRCX) ended Wednesday, December 17, 2025, sharply lower as the broader “AI trade” and semiconductor complex sold off—but the stock nudged higher in after-hours trading, hinting at a possible stabilization heading into Thursday’s session. StockAnalysis+1

Below is what investors should know after the bell and what could matter most before the market opens Thursday, December 18, 2025—including today’s key headlines, fresh analyst moves, and the macro data that could reset risk appetite at 8:30 a.m. ET.


Lam Research stock price after the bell: close vs. after-hours

  • Regular-session close (4:00 p.m. ET):$154.98, down 5.07% on the day.
  • After-hours (as of 6:34 p.m. ET):$156.50, up 0.98% from the close.

The late move matters because today’s decline happened in a risk-off tape for semiconductors, not on a Lam-specific earnings report. A modest after-hours rebound can signal that some traders are treating the selloff as more “macro/sector-driven” than “company-broken.” MarketWatch+1


What happened to LRCX today: a broad semiconductor slide led by AI anxiety

1) The “AI infrastructure” narrative took another hit

A key driver of Wednesday’s selloff was renewed concern that AI data-center buildouts may be running into financing friction, pressuring the same high-momentum names that powered much of 2025’s rally. MarketWatch pointed to rising skepticism around the economics and funding of large data-center projects—citing names like Oracle and CoreWeave as focal points—while also noting the PHLX Semiconductor Index extended a multi-day drawdown.

This matters for Lam because wafer-fab equipment demand ultimately depends on how aggressively customers expand capacity for AI-related compute (logic/foundry) and memory (especially high-bandwidth memory used in AI servers).

2) The overall market tone turned risk-off

Investors.com reported the Nasdaq fell about 1.8% and the S&P 500 fell about 1.6%, with both slipping below key technical levels (notably the 50‑day moving average), a setup that often triggers systematic de-risking and momentum unwinds.

In that kind of tape, even strong fundamental stories can get sold simply because traders are cutting exposure.

3) Lam’s peers were also hit

The weakness wasn’t isolated:

  • Applied Materials (AMAT) fell about 4.08% at the close.
  • KLA (KLAC) fell about 4.20% at the close.

When multiple large-cap tool makers drop in tandem, it usually points to sector rotation and risk sentiment, rather than an issue unique to one company.


Today’s Lam-specific headline: CEO Tim Archer filed a Form 144 to sell shares

One company-specific item that surfaced today: a Refinitiv/Reuters note reported that CEO Tim Archer filed a Form 144 proposing the sale of 163,300 shares, and that the sale was pursuant to a prearranged 10b5‑1 trading plan.

How to interpret it (without overreacting)

  • A Form 144 is essentially a notice of a proposed sale of restricted/control securities—it does not always mean shares were sold immediately at that moment.
  • A 10b5‑1 plan is designed to pre-schedule trades to reduce perceptions of trading on nonpublic information.

Investors often watch insider selling headlines closely, especially during market drawdowns, because they can amplify negative sentiment even when the underlying reason is routine financial planning.

(For context on Form 144’s filing framework, the SEC has explained that certain Form 144 filings must be made electronically via EDGAR under amendments that took effect in 2023.)


Fresh Wall Street forecast today: Mizuho raises its Lam Research price target to $200

A notable positive catalyst from today was an analyst update: Mizuho raised its price target on Lam Research to $200 from $170 and maintained an Outperform rating, according to multiple market reports.

What this signals

Price-target changes don’t move stocks every day—but in a volatile tape they can:

  • reinforce the idea that long-term AI-driven wafer-fab equipment demand remains intact, and
  • provide a “valuation anchor” for dip buyers looking for support after a sharp selloff.

The broader analyst picture (consensus)

MarketBeat data shows a wide target range, with an average target around $158.54 and a high target reaching $210, underscoring that analysts are not aligned on how much upside remains after the big 2025 run.


Today’s fundamental analysis: AI-driven foundry demand remains the bull case

An investment analysis published today (via Nasdaq/Zacks syndication) emphasized that AI-driven foundry demand is supporting Lam’s systems outlook and highlighted valuation/estimate dynamics such as forward multiple comparisons and upward earnings revisions.

The key takeaway: even with day-to-day volatility, much of the long-term Lam thesis still ties to:

  • leading-edge logic/foundry intensity (more steps, more etch/deposition),
  • advanced packaging complexity, and
  • memory spending tied to AI server buildouts.

The biggest “read-through” after hours: Micron earnings beat and upbeat guidance

Semiconductor investors didn’t just get macro headlines today—they also got major earnings from Micron Technology (MU) after the close.

Barron’s reported Micron:

  • beat expectations on EPS ($4.78 vs. ~$3.96 est.) and revenue ($13.6B vs. ~$12.9B est.), and
  • guided to a revenue midpoint around $18.7B for the current quarter, well above some analyst expectations—driving a notable after-hours gain.

Investors.com also flagged Micron’s after-hours jump as a key late-day development and noted it was influencing sentiment in memory-adjacent names.

Why Micron matters for Lam

Micron’s guidance and commentary can affect expectations for:

  • DRAM and NAND pricing, and
  • capacity expansion, especially around HBM (high-bandwidth memory) for AI.

Lam is not a memory maker—but it sells crucial tools into memory and foundry fabs. Stronger memory spending expectations can translate into a firmer demand outlook for wafer-fab equipment over time.


What to watch before the market opens tomorrow (Thursday, Dec. 18, 2025)

If you’re tracking Lam Research into Thursday’s open, the “setup” is less about a single Lam headline and more about whether the market tone improves or deteriorates before 9:30 a.m. ET.

1) 8:30 a.m. ET: U.S. CPI and real earnings (major risk-on / risk-off catalyst)

The U.S. Consumer Price Index for November 2025 and Real Earnings for November 2025 are scheduled for 8:30 a.m. ET on Dec. 18, per the Bureau of Labor Statistics release calendar.

Why it matters for LRCX:

  • Hotter inflation can lift yields and pressure long-duration growth equities.
  • Cooler inflation can revive appetite for semis and AI-linked cyclicals—especially after a multi-day drawdown.

2) 8:30 a.m. ET: jobless claims and other “growth pulse” data

Jobless claims are also set for 8:30 a.m. ET, according to economic calendar trackers.

This matters because markets have been debating whether the economy is cooling fast enough to justify further easing—or whether inflation is sticky enough to keep policy restrictive. Reuters has highlighted how puzzling labor signals are shaping that debate.

3) Any continuation of the AI data-center financing story

Wednesday’s market action showed investors are currently sensitive to headlines that question the pace or economics of AI infrastructure buildouts. MarketWatch described the move as part of a broader reassessment tied to debt financing and project viability.

If that narrative stabilizes overnight, LRCX and peers could see relief; if it worsens, semis may remain under pressure regardless of company-specific fundamentals.

4) Watch premarket action in semis after Micron’s results

With Micron posting a strong report and bullish guide, traders will watch whether that strength spills over into:

  • memory-adjacent names, and
  • equipment makers leveraged to memory and advanced-node intensity.

Micron won’t “fix” the whole sector by itself, but it can change the tone if futures are already trying to bottom.


Key levels and context investors are referencing tonight

Even long-term investors tend to keep an eye on these markers during volatility:

  • 52-week range context: Lam has traded between roughly $56.32 and $169.69 over the past year depending on the data source, and it recently tagged the upper end of that range earlier this month.
  • Where today’s close leaves it: Wednesday’s close near $154.98 places the stock meaningfully off recent highs but still far above spring lows—one reason opinions are split between “healthy correction” and “trend break.” StockAnalysis

Bottom line for LRCX heading into Thursday’s session

Lam Research enters Thursday with two forces pulling in opposite directions:

Bearish near-term forces

  • Semiconductor/AI stocks are under pressure due to renewed worries about the financing and profitability of massive AI infrastructure builds.
  • The broader market’s technical posture weakened as major indexes slipped below key levels.

Constructive signals

  • LRCX bounced in after-hours trading after a steep drop, suggesting at least some bargain-hunting or sentiment stabilization.
  • An analyst raised a major price target to $200 today, reinforcing the longer-term AI-driven equipment demand narrative.
  • Micron’s strong earnings and guidance may help sentiment around the semiconductor capex cycle, especially for memory-related equipment demand.

In the very near term, the market’s direction into the open is likely to hinge less on Lam headlines and more on 8:30 a.m. ET macro data (CPI/earnings/claims) and whether the market decides Wednesday’s selloff was an overreaction or the start of a larger de-risking move.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Australian Firm Neumann Space Pioneers Molybdenum-Fueled Space Propulsion With a Metal “Fuel Rod” Thruster
Previous Story

Australian Firm Neumann Space Pioneers Molybdenum-Fueled Space Propulsion With a Metal “Fuel Rod” Thruster

UK Stock Market Today (18 December 2025): FTSE 100 Set for a Cautious Open as BoE Rate Cut Looms; BP CEO Shock and Currys Results in Focus
Next Story

UK Stock Market Today (18 December 2025): FTSE 100 Set for a Cautious Open as BoE Rate Cut Looms; BP CEO Shock and Currys Results in Focus

Go toTop